Insider transactions

EDGAR

Johnson & Johnson

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
1 transactions, 1,250 shares
Sum of shares × price per share: 257,687.5
Open-market sales (code S)
29 transactions, 622,294 shares
Sum of shares × price per share: 154,384,807.957

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 266

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-12 Filed 2026-11-13Forminard Elizabeth Officer: EVP, Chief Legal Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)13,072151.41
1,979,231.52

Derived: shares × price per share. Exact value 1979231.52.

30,066Direct (D) No— Open filing 0000200406-26-000199 Read from the filing’s XML Dispute this row
2026-11-12 Filed 2026-11-13Forminard Elizabeth Officer: EVP, Chief Legal Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)13,072284.39
3,717,546.08

Derived: shares × price per share. Exact value 3717546.08.

16,994Direct (D) No— Open filing 0000200406-26-000199 Read from the filing’s XML Dispute this row
2026-11-12 Filed 2026-11-13Forminard Elizabeth Officer: EVP, Chief Legal Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Options (Right to Buy) — underlying Common Stock (13,072) — exercise price 151.41
Disposed (D)13,0720—0Direct (D) No
F1
  • F1 Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Open filing 0000200406-26-000199 Read from the filing’s XML Dispute this row
2026-09-08 Filed 2026-09-10Woods Eugene A. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Deferred Share Units — underlying Common Stock (135.717)
Acquired (A)135.717276.31
37,499.96427

Derived: shares × price per share. Exact value 37499.96427.

6,578.771Direct (D) No
F1, F2
  • F1 Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.
  • F2 Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
Open filing 0000200406-26-000184 Read from the filing’s XML Dispute this row
2026-09-08 Filed 2026-09-10Pinto Daniel E Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Deferred Share Units — underlying Common Stock (113.098)
Acquired (A)113.098276.31
31,250.10838

Derived: shares × price per share. Exact value 31250.10838.

2,445.177Direct (D) No
F1, F2
  • F1 Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.
  • F2 Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
Open filing 0000200406-26-000185 Read from the filing’s XML Dispute this row
2026-09-08 Filed 2026-09-10HEWSON MARILLYN A Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Deferred Share Units — underlying Common Stock (180.956)
Acquired (A)180.956276.31
49,999.95236

Derived: shares × price per share. Exact value 49999.95236.

16,049.417Direct (D) No
F1, F2
  • F1 Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.
  • F2 Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
Open filing 0000200406-26-000183 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-04Schmid Timothy Officer: EVP, WW Chair, MedTech
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)11,070131.94
1,460,575.8

Derived: shares × price per share. Exact value 1460575.80.

36,517Direct (D) No— Open filing 0000200406-26-000179 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-04Schmid Timothy Officer: EVP, WW Chair, MedTech
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)11,070274.74
3,041,371.8

Derived: shares × price per share. Exact value 3041371.80.

25,447Direct (D) No— Open filing 0000200406-26-000179 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-04Schmid Timothy Officer: EVP, WW Chair, MedTech
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)22,527151.41
3,410,813.07

Derived: shares × price per share. Exact value 3410813.07.

47,974Direct (D) No— Open filing 0000200406-26-000179 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-04Schmid Timothy Officer: EVP, WW Chair, MedTech
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)22,527274.74
6,189,067.98

Derived: shares × price per share. Exact value 6189067.98.

25,447Direct (D) No— Open filing 0000200406-26-000179 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-04Schmid Timothy Officer: EVP, WW Chair, MedTech
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Options (Right to Buy) — underlying Common Stock (11,070) — exercise price 131.94
Disposed (D)11,0700—0Direct (D) No
F3
  • F3 Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Open filing 0000200406-26-000179 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-04Schmid Timothy Officer: EVP, WW Chair, MedTech
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Options (Right to Buy) — underlying Common Stock (22,527) — exercise price 151.41
Disposed (D)22,5270—0Direct (D) No
F3
  • F3 Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Open filing 0000200406-26-000179 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-18Taubert Jennifer L Officer: EVP, WWC. Innovative Medicine
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)15,000115.67
1,735,050

Derived: shares × price per share. Exact value 1735050.00.

209,451.001Direct (D) No— Open filing 0000200406-26-000175 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-18Taubert Jennifer L Officer: EVP, WWC. Innovative Medicine
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)15,000263.36
3,950,400

Derived: shares × price per share. Exact value 3950400.00.

194,451.001Direct (D) No
F1
  • F1 This transaction was executed in multiple trades at prices ranging from $263.30 to $263.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0000200406-26-000175 Read from the filing’s XML Dispute this row
2026-08-17 Filed 2026-08-18Taubert Jennifer L Officer: EVP, WWC. Innovative Medicine
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Options (Right to Buy) — underlying Common Stock (15,000) — exercise price 115.67
Disposed (D)15,0000—28,712Direct (D) No
F2
  • F2 Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Open filing 0000200406-26-000175 Read from the filing’s XML Dispute this row
2026-08-13 Filed 2026-08-14Duato Joaquin Director · Officer: CEO and Chairman of the Board
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)123,291115.67
14,261,069.97

Derived: shares × price per share. Exact value 14261069.97.

399,258Direct (D) No— Open filing 0000200406-26-000173 Read from the filing’s XML Dispute this row
2026-08-13 Filed 2026-08-14Duato Joaquin Director · Officer: CEO and Chairman of the Board
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)20,976262
5,495,712

Derived: shares × price per share. Exact value 5495712.

378,282Direct (D) No— Open filing 0000200406-26-000173 Read from the filing’s XML Dispute this row
2026-08-13 Filed 2026-08-14Duato Joaquin Director · Officer: CEO and Chairman of the Board
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)102,315261
26,704,215

Derived: shares × price per share. Exact value 26704215.

275,967Direct (D) No— Open filing 0000200406-26-000173 Read from the filing’s XML Dispute this row
2026-08-13 Filed 2026-08-14Duato Joaquin Director · Officer: CEO and Chairman of the Board
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Options (Right to Buy) — underlying Common Stock (123,291) — exercise price 115.67
Disposed (D)123,2910—0Direct (D) No
F2
  • F2 Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Open filing 0000200406-26-000173 Read from the filing’s XML Dispute this row
2026-08-06 Filed 2026-08-07Forminard Elizabeth Officer: EVP, Chief Legal Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)9,344131.94
1,232,847.36

Derived: shares × price per share. Exact value 1232847.36.

32,912Direct (D) No— Open filing 0000200406-26-000169 Read from the filing’s XML Dispute this row
2026-08-06 Filed 2026-08-07Forminard Elizabeth Officer: EVP, Chief Legal Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)9,344257.755
2,408,462.72

Derived: shares × price per share. Exact value 2408462.720.

23,568Direct (D) No— Open filing 0000200406-26-000169 Read from the filing’s XML Dispute this row
2026-08-06 Filed 2026-08-07Forminard Elizabeth Officer: EVP, Chief Legal Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)6,574255.932
1,682,496.968

Derived: shares × price per share. Exact value 1682496.968.

16,994Direct (D) No— Open filing 0000200406-26-000169 Read from the filing’s XML Dispute this row
2026-08-06 Filed 2026-08-07Forminard Elizabeth Officer: EVP, Chief Legal Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Options (Right to Buy) — underlying Common Stock (9,344) — exercise price 131.94
Disposed (D)9,3440—0Direct (D) No
F1
  • F1 Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Open filing 0000200406-26-000169 Read from the filing’s XML Dispute this row
2026-08-05 Filed 2026-08-07Duato Joaquin Director · Officer: CEO and Chairman of the Board
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)41,957258.056
10,827,255.592

Derived: shares × price per share. Exact value 10827255.592.

282,490Direct (D) No
F1
  • F1 This transaction was executed in multiple trades at prices ranging from $257.53 to $258.505. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0000200406-26-000171 Read from the filing’s XML Dispute this row
2026-08-05 Filed 2026-08-07Duato Joaquin Director · Officer: CEO and Chairman of the Board
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)6,523258.739
1,687,754.497

Derived: shares × price per share. Exact value 1687754.497.

275,967Direct (D) No
F2
  • F2 This transaction was executed in multiple trades at prices ranging from $258.535 to $259.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0000200406-26-000171 Read from the filing’s XML Dispute this row
2026-07-20 Filed 2026-07-21Broadhurst Vanessa Officer: EVP, Global Corp Affairs
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)11,129129.51
1,441,316.79

Derived: shares × price per share. Exact value 1441316.79.

34,132Direct (D) No— Open filing 0000200406-26-000148 Read from the filing’s XML Dispute this row
2026-07-20 Filed 2026-07-21Broadhurst Vanessa Officer: EVP, Global Corp Affairs
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)11,925131.94
1,573,384.5

Derived: shares × price per share. Exact value 1573384.50.

46,057Direct (D) No— Open filing 0000200406-26-000148 Read from the filing’s XML Dispute this row
2026-07-20 Filed 2026-07-21Broadhurst Vanessa Officer: EVP, Global Corp Affairs
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)23,054251.266
5,792,686.364

Derived: shares × price per share. Exact value 5792686.364.

23,003Direct (D) No
F1
  • F1 This transaction was executed in multiple trades at prices ranging from $251.09 to $251.555. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0000200406-26-000148 Read from the filing’s XML Dispute this row
2026-07-20 Filed 2026-07-21Broadhurst Vanessa Officer: EVP, Global Corp Affairs
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Options (Right to Buy) — underlying Common Stock (11,129) — exercise price 129.51
Disposed (D)11,1290—0Direct (D) No
F2
  • F2 Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Open filing 0000200406-26-000148 Read from the filing’s XML Dispute this row
2026-07-20 Filed 2026-07-21Broadhurst Vanessa Officer: EVP, Global Corp Affairs
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Options (Right to Buy) — underlying Common Stock (11,925) — exercise price 131.94
Disposed (D)11,9250—0Direct (D) No
F2
  • F2 Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Open filing 0000200406-26-000148 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-12Wengel Kathryn E Officer: EVP, Chief TO and Risk Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)10,000115.67
1,156,700

Derived: shares × price per share. Exact value 1156700.00.

124,287.8735Direct (D) No— Open filing 0000200406-26-000127 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-12Wengel Kathryn E Officer: EVP, Chief TO and Risk Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)10,000241.15
2,411,500

Derived: shares × price per share. Exact value 2411500.00.

114,287.8735Direct (D) No
F1
  • F1 This transaction was executed in multiple trades at prices ranging from $240.14 to $240.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0000200406-26-000127 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-12Wengel Kathryn E Officer: EVP, Chief TO and Risk Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Options (Right to Buy) — underlying Common Stock (10,000) — exercise price 115.67
Disposed (D)10,0000—32,965Direct (D) No
F4
  • F4 Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Open filing 0000200406-26-000127 Read from the filing’s XML Dispute this row
2026-06-09 Filed 2026-06-11Woods Eugene A. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Deferred Share Units — underlying Common Stock (161.089)
Acquired (A)161.089232.79
37,499.90831

Derived: shares × price per share. Exact value 37499.90831.

6,411.959Direct (D) No
F1, F2
  • F1 Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.
  • F2 Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
Open filing 0000200406-26-000125 Read from the filing’s XML Dispute this row
2026-06-09 Filed 2026-06-11Pinto Daniel E Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Deferred Share Units — underlying Common Stock (134.241)
Acquired (A)134.241232.79
31,249.96239

Derived: shares × price per share. Exact value 31249.96239.

2,320.824Direct (D) No
F1, F2
  • F1 Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.
  • F2 Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
Open filing 0000200406-26-000123 Read from the filing’s XML Dispute this row
2026-06-09 Filed 2026-06-11HEWSON MARILLYN A Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Deferred Share Units — underlying Common Stock (214.786)
Acquired (A)214.786232.79
50,000.03294

Derived: shares × price per share. Exact value 50000.03294.

15,791.877Direct (D) No
F1, F2
  • F1 Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.
  • F2 Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
Open filing 0000200406-26-000121 Read from the filing’s XML Dispute this row
2026-05-01 Filed 2026-05-04REED JOHN C Officer: EVP, Innovative Medicine, RD
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)25,2550—35,913Direct (D) No
F1
  • F1 Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.
Open filing 0000200406-26-000115 Read from the filing’s XML Dispute this row
2026-05-01 Filed 2026-05-04REED JOHN C Officer: EVP, Innovative Medicine, RD
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)11,002229.85
2,528,809.7

Derived: shares × price per share. Exact value 2528809.70.

24,911Direct (D) No
F2
  • F2 Shares withheld for payment of taxes upon vesting of RSUs.
Open filing 0000200406-26-000115 Read from the filing’s XML Dispute this row
2026-05-01 Filed 2026-05-04REED JOHN C Officer: EVP, Innovative Medicine, RD
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Share Units — underlying Common Stock (25,255)
Disposed (D)25,2550—0Direct (D) No
F1
  • F1 Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on May 1, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.
Open filing 0000200406-26-000115 Read from the filing’s XML Dispute this row
2026-04-23 Filed 2026-04-27Woods Eugene A. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Deferred Share Units — underlying Common Stock (975)
Acquired (A)9750—6,215.094Direct (D) No
F1, F2
  • F1 Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).
  • F2 Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
Open filing 0000200406-26-000113 Read from the filing’s XML Dispute this row
2026-04-23 Filed 2026-04-27Beckerle Mary C Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Deferred Share Units — underlying Common Stock (975)
Acquired (A)9750—16,797.7393Direct (D) No
F1, F2
  • F1 Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).
  • F2 Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
Open filing 0000200406-26-000092 Read from the filing’s XML Dispute this row
2026-04-23 Filed 2026-04-27Johnson Paula A Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Deferred Share Units — underlying Common Stock (975)
Acquired (A)9750—5,359.3973Direct (D) No
F1, F2
  • F1 Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).
  • F2 Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
Open filing 0000200406-26-000098 Read from the filing’s XML Dispute this row
2026-04-23 Filed 2026-04-27HEWSON MARILLYN A Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Deferred Share Units — underlying Common Stock (975)
Acquired (A)9750—15,487.939Direct (D) No
F1, F2
  • F1 Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).
  • F2 Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
Open filing 0000200406-26-000096 Read from the filing’s XML Dispute this row
2026-04-23 Filed 2026-04-27WEINBERGER MARK A Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Deferred Share Units — underlying Common Stock (975)
Acquired (A)9750—12,010.408Direct (D) No
F1, F2
  • F1 Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).
  • F2 Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
Open filing 0000200406-26-000108 Read from the filing’s XML Dispute this row
2026-04-23 Filed 2026-04-27Pinto Daniel E Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Deferred Share Units — underlying Common Stock (1,712)
Acquired (A)1,7120—2,174.069Direct (D) No
F1, F2
  • F1 Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).
  • F2 Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
Open filing 0000200406-26-000106 Read from the filing’s XML Dispute this row
2026-04-23 Filed 2026-04-27MORIKIS JOHN G Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Deferred Share Units — underlying Common Stock (1,540)
Acquired (A)1,5400—1,540Direct (D) No
F1
  • F1 Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).
Open filing 0000200406-26-000104 Read from the filing’s XML Dispute this row
2026-04-23 Filed 2026-04-27Joly Hubert Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Deferred Share Units — underlying Common Stock (975)
Acquired (A)9750—9,183.605Direct (D) No
F1, F2
  • F1 Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).
  • F2 Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
Open filing 0000200406-26-000100 Read from the filing’s XML Dispute this row
2026-04-23 Filed 2026-04-27McClellan Mark B. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Deferred Share Units — underlying Common Stock (975)
Acquired (A)9750—21,278.593Direct (D) No
F1, F2
  • F1 Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).
  • F2 Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
Open filing 0000200406-26-000102 Read from the filing’s XML Dispute this row
2026-04-23 Filed 2026-04-27West Nadja Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Deferred Share Units — underlying Common Stock (975)
Acquired (A)9750—7,730.0491Direct (D) No
F1, F2
  • F1 Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).
  • F2 Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
Open filing 0000200406-26-000111 Read from the filing’s XML Dispute this row
2026-04-23 Filed 2026-04-27Doudna Jennifer A Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Deferred Share Units — underlying Common Stock (975)
Acquired (A)9750—10,899.1714Direct (D) No
F1, F2
  • F1 Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date).
  • F2 Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
Open filing 0000200406-26-000094 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–50 of 4,880

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
BlackRock, Inc. Partly reported under another manager209,718,001 SH55,520,743,704 dollarsLower by 2,380,263 Prior quarter: 212,098,264Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 157,757,243 SH41,764,652,512 dollarsHigher by 530,869 Prior quarter: 157,226,374Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
STATE STREET CORP Partly reported under another manager133,971,339 SH35,467,572,287 dollarsHigher by 195,314 Prior quarter: 133,776,025Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 65,651,392 SH17,380,549,518 dollarsHigher by 1,280,576 Prior quarter: 64,370,816Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager65,497,363 SH17,301,766,484 dollarsHigher by 6,410,946 Prior quarter: 59,086,417Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager61,752,701 SH16,523,170,777 dollarsHigher by 3,451,092 Prior quarter: 58,301,609Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
MORGAN STANLEY Partly reported under another manager44,682,305 SH11,829,194,059 dollarsLower by 125,949 Prior quarter: 44,808,254Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO Partly reported under another manager31,590,952 SH8,363,388,632 dollarsUnchanged Prior quarter: 31,590,952Open filing 0000315032-26-000005 Filed 2026-11-12 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager28,197,333 SH7,464,961,936 dollarsLower by 594,731 Prior quarter: 28,792,064Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
Capital World Investors Partly reported under another manager26,316,977 SH6,967,487,920 dollarsHigher by 11,101,962 Prior quarter: 15,215,015Open filing 0001422849-26-000169 Filed 2026-11-12 Dispute this row
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Partly reported under another manager23,110,038 SH6,118,151,462 dollarsHigher by 4,693,915 Prior quarter: 18,416,123Open filing 0000861177-26-000005 Filed 2026-11-16 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager22,788,472 SH6,033,020,012 dollarsLower by 649,669 Prior quarter: 23,438,141Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager21,951,476 SH5,811,435 dollarsLower by 1,045,402 Prior quarter: 22,996,878Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager21,579,635 SH5,712,992,899 dollarsLower by 103,712 Prior quarter: 21,683,347Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
Legal General Group Plc Partly reported under another manager19,202,137 SH5,083,573,754 dollarsLower by 84,767 Prior quarter: 19,286,904Open filing 0001495115-26-000075 Filed 2026-11-16 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Partly reported under another manager19,017,225 SH5,036,228,823 dollarsLower by 108,940 Prior quarter: 19,126,165Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager18,970,498 SH5,022,249,641 dollarsLower by 3,618,198 Prior quarter: 22,588,696Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row
FMR LLC Partly reported under another manager18,663,261 SH4,940,911,708 dollarsLower by 3,932,305 Prior quarter: 22,595,566Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
WELLS FARGO COMPANY/MN Partly reported under another manager17,289,245 SH4,577,154,550 dollarsLower by 85,188 Prior quarter: 17,374,433Open filing 0000072971-26-000342 Filed 2026-11-16 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager16,997,959 SH4,500,039,614 dollarsLower by 2,724,585 Prior quarter: 19,722,544Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
ROYAL BANK OF CANADA Partly reported under another manager15,303,536 SH4,051,460,000 dollarsHigher by 2,092,061 Prior quarter: 13,211,475Open filing 0001140361-26-044123 Filed 2026-11-16 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager14,996,077 SH3,970,271,770 dollarsLower by 389,479 Prior quarter: 15,385,556Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
Invesco Ltd. Partly reported under another manager14,980,632 SH3,965,972,555 dollarsLower by 693,461 Prior quarter: 15,674,093Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
Fisher Asset Management, LLC Partly reported under another manager14,837,126 SH3,927,981,007 dollarsHigher by 1,530,070 Prior quarter: 13,307,056Open filing 0000850529-26-000009 Filed 2026-11-06 Dispute this row
DEUTSCHE BANK AG\ Partly reported under another manager13,968,174 SH3,697,934,385 dollarsLower by 1,693,149 Prior quarter: 15,661,323Open filing 0000948046-26-000083 Filed 2026-11-06 Dispute this row
VANGUARD FIDUCIARY TRUST CO 13,604,863 SH3,601,751,431 dollarsHigher by 87,793 Prior quarter: 13,517,070Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
Nuveen, LLC Partly reported under another manager13,525,275 SH3,580,681,214 dollarsHigher by 546,756 Prior quarter: 12,978,519Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
AMERIPRISE FINANCIAL INC Partly reported under another manager13,430,042 SH3,556,061,567 dollarsHigher by 28,351 Prior quarter: 13,401,691Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row
Amundi Partly reported under another manager12,048,226 SH3,189,647,352 dollarsLower by 1,069,431 Prior quarter: 13,117,657Open filing 0001172661-26-004884 Filed 2026-11-06 Dispute this row
UBS Group AG Partly reported under another manager11,787,299 SH3,120,569,536 dollarsHigher by 750,408 Prior quarter: 11,036,891Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
Mirabaud Asset Management Ltd 11,287,000 PRN3,020,063 dollarsNot in the prior quarter’s filings read Open filing 0001680493-26-000018 Filed 2026-11-09 Dispute this row
FRANKLIN TEMPLETON INC Partly reported under another manager10,948,332 SH3,025,267,063 dollarsHigher by 861,730 Prior quarter: 10,086,602Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row
RAYMOND JAMES FINANCIAL INC Partly reported under another manager10,407,686 SH2,755,331,244 dollarsHigher by 293,376 Prior quarter: 10,114,310Open filing 0000720005-26-000081 Filed 2026-11-12 Dispute this row
HighTower Advisors, LLC 9,849,187 SH2,607,473,737 dollarsLower by 43,580 Prior quarter: 9,892,767Open filing 0001085146-26-000933 Filed 2026-11-10 Dispute this row
HSBC HOLDINGS PLC Partly reported under another manager9,230,318 SH2,445,906,414 dollarsHigher by 223,821 Prior quarter: 9,006,497Open filing 0000873630-26-000005 Filed 2026-11-16 Dispute this row
ALLIANCEBERNSTEIN L.P. Partly reported under another manager8,221,011 SH2,176,672,038 dollarsHigher by 1,353,746 Prior quarter: 6,867,265Open filing 0001109448-26-000342 Filed 2026-11-16 Dispute this row
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ Partly reported under another manager7,945,444 SH2,131,921,074 dollarsLower by 2,593,654 Prior quarter: 10,539,098Open filing 0000912938-26-001073 Filed 2026-11-12 Dispute this row
Janus Henderson Group Ltd. Partly reported under another manager7,624,933 SH2,018,741,143 dollarsNot in the prior quarter’s filings read Open filing 0001085146-26-000952 Filed 2026-11-16 Dispute this row
Grantham, Mayo, Van Otterloo Co. LLC 6,956,949 SH1,841,783,218 dollarsLower by 153,184 Prior quarter: 7,110,133Open filing 0001072613-26-000864 Filed 2026-11-13 Dispute this row
Swiss National Bank 6,584,107 SH1,743,076,487 dollarsLower by 209,300 Prior quarter: 6,793,407Open filing 0001582202-26-000008 Filed 2026-11-12 Dispute this row
Ninety One UK Ltd 6,491,294 SH1,718,505,190 dollarsLower by 285,326 Prior quarter: 6,776,620Open filing 0001140361-26-039718 Filed 2026-10-15 Dispute this row
Mitsubishi UFJ Asset Management Co., Ltd. Partly reported under another manager6,438,670 SH1,704,469,528 dollarsHigher by 363,300 Prior quarter: 6,075,370Open filing 0001193125-26-447983 Filed 2026-11-05 Dispute this row
PNC Financial Services Group, Inc. Partly reported under another manager5,671,724 SH1,501,532,217 dollarsHigher by 7,449 Prior quarter: 5,664,275Open filing 0001193125-26-450808 Filed 2026-11-06 Dispute this row
California Public Employees Retirement System 5,641,232 SH1,493,459,760 dollarsHigher by 671,250 Prior quarter: 4,969,982Open filing 0000919079-26-000013 Filed 2026-11-16 Dispute this row
Sumitomo Mitsui Trust Group, Inc. Partly reported under another manager5,475,151 SH1,449,491,476 dollarsLower by 185,703 Prior quarter: 5,660,854Open filing 0001214659-26-013361 Filed 2026-10-29 Dispute this row
VANGUARD ASSET MANAGEMENT, Ltd 5,380,474 SH1,424,426,687 dollarsHigher by 420,405 Prior quarter: 4,960,069Open filing 0001680208-26-000018 Filed 2026-11-13 Dispute this row
Vanguard Global Advisers, LLC 5,378,974 SH1,424,029,577 dollarsHigher by 134,829 Prior quarter: 5,244,145Open filing 0001811242-26-000017 Filed 2026-11-13 Dispute this row
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main Partly reported under another manager5,258,232 SH1,392,066,246 dollarsLower by 120,073 Prior quarter: 5,378,305Open filing 0000905148-26-004847 Filed 2026-11-16 Dispute this row
National Pension Service 5,255,590 SH1,391,364,897 dollarsHigher by 28,622 Prior quarter: 5,226,968Open filing 0001193125-26-456954 Filed 2026-11-12 Dispute this row
Capital Research Global Investors Partly reported under another manager5,242,120 SH1,387,807,123 dollarsLower by 2,922,425 Prior quarter: 8,164,545Open filing 0001422848-26-000129 Filed 2026-11-12 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • NORGES BANK 31,825,084 SH
  • Sixth Street Partners Management Company, L.P. 19,126,165 SH
  • Jupiter Topco LLC 7,746,487 SH
  • SG Americas Securities, LLC 5,280,140 SH
  • SG Americas Securities, LLC 1,151,100 SH
  • Tredje AP-fonden 753,095 SH
  • HM PAYSON CO 391,709 SH
  • VOLORIDGE INVESTMENT MANAGEMENT, LLC 363,570 SH
  • NewEdge Wealth, LLC 255,223 SH
  • RNC CAPITAL MANAGEMENT LLC 191,013 SH
  • Pacer Advisors, Inc. 183,172 SH
  • JOHNSON INVESTMENT COUNSEL INC 170,334 SH
  • Smith Group Asset Management, LLC 159,696 SH
  • ST GERMAIN D J CO INC 146,636 SH
  • World Investment Advisors 138,212 SH
  • Arkadios Wealth Advisors 114,657 SH
  • SPIREPOINT PRIVATE CLIENT, LLC 108,989 SH
  • Summit Trail Advisors, LLC 102,279 SH
  • Polar Asset Management Partners Inc. 100,000 SH
  • Kinsale Capital Group, Inc. 84,464 SH
  • CAPITAL FUND MANAGEMENT S.A. 82,341 SH
  • FAIRFAX FINANCIAL HOLDINGS LTD/ CAN 73,400 SH
  • LONE PEAK GLOBAL INVESTORS LLC 66,091 SH
  • ROWLANDMILLER PARTNERS.ADV 64,152 SH
  • CAISSE DES DEPOTS ET CONSIGNATIONS 58,227 SH
  • Wahed Invest LLC 57,345 SH
  • Arvest Bank Trust Division 57,057 SH
  • UNITED BANK 54,544 SH
  • MANAGED ASSET PORTFOLIOS, LLC 53,838 SH
  • TRANSCEND CAPITAL ADVISORS, LLC 43,125 SH
  • WEBSTER BANK, N. A. 39,734 SH
  • Baader Bank Aktiengesellschaft 38,394 SH
  • Field Main Bank 36,353 SH
  • GOLDMAN SACHS GROUP INC 30,300 SH
  • LRT Capital Management, LLC 30,168 SH
  • KEYSTONE INVESTORS PTE LTD 29,987 SH
  • NORTH STAR ASSET MANAGEMENT INC 28,155 SH
  • PLATINUM INVESTMENT MANAGEMENT LTD 27,830 SH
  • DoubleLine ETF Adviser LP 26,686 SH
  • BUFFALO BUSINESS ESTATE SERVICES LTD 24,887 PRN
  • Main Street Financial Solutions, LLC 24,186 SH
  • 44 WEALTH MANAGEMENT LLC 23,812 SH
  • Ilex Capital Partners (UK) LLP 22,637 SH
  • CAPITAL ADVISORS INC/OK 22,507 SH
  • Newman Dignan Sheerar, Inc. 21,236 SH
  • Jupiter Wealth Management LLC 20,696 SH
  • Venturi Wealth Management, LLC 19,172 SH
  • Holocene Advisors, LP 18,956 SH
  • SECURITY NATIONAL BANK OF SIOUX CITY IOWA /IA/ 18,143 SH
  • Wellington Shields Co., LLC 17,288 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

Showing 1–50 of 297

House members’ trades in this company, newest report first, as filed
MemberTransaction dateTypeAmountOwnerReport
Hon. Thomas H. Kean Jr (NJ07)2026-10-27Sale (partial)$1,001 - $15,0002026-11-19
Hon. Thomas H. Kean Jr (NJ07)2026-09-30Sale (partial)$1,001 - $15,0002026-10-30
Hon. Lloyd Doggett (TX37)2026-09-08Purchase$1,001 - $15,0002026-10-05
Hon. Thomas H. Kean Jr (NJ07)2026-08-27Sale (partial)$1,001 - $15,0002026-09-12
Hon. Richard Dean Dr McCormick (GA06)2026-07-30Sale$1,001 - $15,0002026-08-14
Hon. Thomas H. Kean Jr (NJ07)2026-06-29Sale (partial)$1,001 - $15,0002026-07-15
Hon. Thomas H. Kean Jr (NJ07)2026-06-02Sale (partial)$1,001 - $15,0002026-07-15
Hon. Lloyd Doggett (TX37)2026-06-09Purchase$1,001 - $15,0002026-07-06
Hon. Thomas H. Kean Jr (NJ07)2026-03-26Sale (partial)$1,001 - $15,0002026-04-13
Hon. Richard Dean Dr McCormick (GA06)2026-03-19Sale (partial)$1,001 - $15,0002026-04-07
Hon. Richard Dean Dr McCormick (GA06)2026-03-19Sale (partial)$1,001 - $15,0002026-04-07
Hon. Lloyd Doggett (TX37)2026-03-10Purchase$1,001 - $15,0002026-04-06
Hon. Thomas H. Kean Jr (NJ07)2026-01-23Sale (partial)$15,001 - $50,0002026-02-19
Hon. Julie Johnson (TX32)2025-12-18Sale$1,001 - $15,000JT2026-01-15
Hon. Lloyd Doggett (TX37)2025-12-09Purchase$1,001 - $15,0002026-01-02
Hon. Thomas H. Kean Jr (NJ07)2025-11-20Sale (partial)$15,001 - $50,0002025-12-19
Hon. Julie Johnson (TX32)2025-11-13Sale (partial)$1,001 - $15,000JT2025-12-11
Hon. Richard Dean Dr McCormick (GA06)2025-11-05Purchase$1,001 - $15,0002025-12-09
Hon. Jared Moskowitz (FL23)2025-10-10Sale (partial)$1,001 - $15,000DC2025-11-22
Hon. Jared Moskowitz (FL23)2025-10-10Sale (partial)$1,001 - $15,000DC2025-11-22
Hon. Lisa McClain (MI09)2025-10-30Sale$1,001 - $15,000SP2025-11-21
Hon. Lisa McClain (MI09)2025-10-30Purchase$1,001 - $15,000SP2025-11-21
Hon. Lisa McClain (MI09)2025-10-31Sale$1,001 - $15,000SP2025-11-21
Hon. Valerie Hoyle (OR04)2025-09-23Sale$1,001 - $15,000SP2025-10-10
Hon. Sheri Biggs (SC03)2025-03-19Sale$15,001 - $50,000SP2025-10-05
Hon. Richard Dean Dr McCormick (GA06)2023-03-15Purchase$1,001 - $15,0002025-09-17
Hon. Lisa McClain (MI09)2025-08-04Purchase$1,001 - $15,000SP2025-09-12
Hon. Valerie Hoyle (OR04)2024-10-29Purchase$1,001 - $15,000SP2025-09-12
Hon. Kelly Louise Morrison (MN03)2025-08-19Sale (partial)$1,001 - $15,0002025-09-11
Hon. Julie Johnson (TX32)2025-08-14Sale (partial)$1,001 - $15,000JT2025-09-11
Hon. Ritchie John Torres (NY15)2024-09-26Purchase$1,001 - $15,0002025-08-20
Hon. Thomas H. Kean Jr (NJ07)2025-07-31Sale (partial)$15,001 - $50,0002025-08-20
Hon. Lisa McClain (MI09)2025-06-17Purchase$1,001 - $15,000SP2025-08-13
Hon. Lisa McClain (MI09)2025-06-24Sale$1,001 - $15,000SP2025-08-13
Hon. Scott Scott Franklin (FL18)2025-06-16Sale$15,001 - $50,000JT2025-07-14
Hon. Lloyd Doggett (TX37)2025-06-10Purchase$1,001 - $15,0002025-07-07
Hon. Scott Scott Franklin (FL18)2024-08-07Purchase$1,001 - $15,000SP2025-07-03
Hon. Jefferson Shreve (IN06)2025-05-12Sale$50,001 - $100,0002025-06-22
Hon. Pete Sessions (TX17)2025-06-12Sale$15,001 - $50,000SP2025-06-21
Hon. Gilbert Cisneros (CA31)2025-05-30Purchase$15,001 - $50,0002025-06-06
Hon. Julie Johnson (TX32)2025-04-01Sale$1,001 - $15,000JT2025-05-14
Hon. Josh Gottheimer (NJ05)2025-04-09Sale (partial)$1,001 - $15,000JT2025-05-14
Hon. Bruce Westerman (AR04)2025-04-21Sale$1,001 - $15,0002025-05-12
Hon. Gilbert Cisneros (CA31)2025-04-29Sale (partial)$1,001 - $15,0002025-05-06
Hon. Marjorie Taylor Greene (GA14)2025-05-05Purchase$1,001 - $15,0002025-05-06
Hon. Rob Bresnahan (PA08)2025-04-08Sale$1,001 - $15,0002025-04-28
Hon. George Whitesides (CA27)2025-03-24Sale$100,001 - $250,0002025-04-23
Hon. Bruce Westerman (AR04)2025-03-03Purchase$1,001 - $15,0002025-04-16
Hon. Jefferson Shreve (IN06)2025-03-05Purchase$15,001 - $50,0002025-04-11
Hon. Josh Gottheimer (NJ05)2025-03-07Sale (partial)$1,001 - $15,000JT2025-04-10

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Vanguard Capital Management Common Stock7.49180,631,22803/31/2026 Filed 2026-05-01SCHEDULE 13GOpen filing 0002100119-26-001295 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-26SCHEDULE 13G/AAmendment 10Open filing 0000102909-26-000380 Dispute this row
The Vanguard Group Common Stock10.10243,455,13501/30/2026 Filed 2026-02-05SCHEDULE 13G/AAmendment 10Open filing 0000102909-26-000328 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,748,233 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015164,615
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to Johnson & Johnson